What is the recommended treatment for latent syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Latent Stage Syphilis

For early latent syphilis (duration <1 year), treat with benzathine penicillin G 2.4 million units IM as a single dose; for late latent syphilis or latent syphilis of unknown duration, treat with benzathine penicillin G 7.2 million units total administered as three doses of 2.4 million units IM at weekly intervals. 1

Treatment Algorithm by Stage

Early Latent Syphilis (Duration <1 Year)

  • Benzathine penicillin G 2.4 million units IM in a single dose is the recommended first-line treatment 1
  • Early latent syphilis is diagnosed when patients have documented seroconversion, unequivocal symptoms of primary or secondary syphilis within the past year, or a sex partner with documented early syphilis 1

Late Latent Syphilis or Latent Syphilis of Unknown Duration

  • Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at 1-week intervals 1
  • If a patient misses a dose during weekly therapy, an interval of 10-14 days between doses may be acceptable before restarting the sequence, though this is not acceptable for pregnant patients who must repeat the full course 1

Pre-Treatment Evaluation

CSF Examination Indications

Perform lumbar puncture before treatment if the patient has any of the following criteria:

  • Neurologic or ophthalmic signs or symptoms 1
  • Evidence of active tertiary syphilis (aortitis, gumma, iritis) 1
  • Treatment failure 1
  • HIV infection with late latent syphilis or syphilis of unknown duration 1
  • Serum nontreponemal titer ≥1:32, unless duration of infection is known to be <1 year 1
  • Nonpenicillin therapy planned, unless duration is known to be <1 year 1

If CSF shows abnormalities consistent with neurosyphilis, treat as neurosyphilis with aqueous crystalline penicillin G 18-24 million units per day IV for 10-14 days 1

Additional Baseline Assessment

  • All patients with latent syphilis should be evaluated clinically for tertiary disease manifestations 1
  • All syphilis patients must be tested for HIV 1

Alternative Regimens for Penicillin Allergy

Non-Pregnant Patients

Only use alternative regimens after CSF examination has excluded neurosyphilis 1

  • Early latent syphilis: Doxycycline 100 mg orally twice daily for 14 days OR tetracycline 500 mg orally four times daily for 14 days 1, 2
  • Late latent syphilis or unknown duration: Doxycycline 100 mg orally twice daily for 28 days OR tetracycline 500 mg orally four times daily for 28 days 1, 2

Critical caveat: The effectiveness of non-penicillin alternatives has not been well documented, and these therapies should be used only with close serologic and clinical follow-up 1

Pregnant Patients

Pregnant patients allergic to penicillin must be desensitized and treated with penicillin - there are no acceptable alternatives 1

Follow-Up Protocol

Serologic Monitoring

  • Repeat quantitative nontreponemal serologic tests at 6,12, and 24 months after treatment 1
  • For HIV-infected patients, some experts recommend monitoring at 3-month intervals instead of 6-month intervals 3

Treatment Failure Criteria

Re-treat the patient if any of the following occur:

  • Titers increase fourfold (e.g., from 1:8 to 1:32) 1
  • An initially high titer (≥1:32) fails to decline at least fourfold within 12-24 months 1
  • Signs or symptoms attributable to syphilis develop 1

When treatment failure occurs, evaluate for neurosyphilis with CSF examination and re-treat appropriately 1

Pediatric Considerations

Pre-Treatment Assessment

  • After the newborn period, children diagnosed with syphilis should have CSF examination to exclude neurosyphilis 1
  • Review birth and maternal medical records to assess whether the child has congenital or acquired syphilis 1

Pediatric Dosing

  • Early latent syphilis: Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) in a single dose 1
  • Late latent syphilis or unknown duration: Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) administered as three doses at 1-week intervals (total 150,000 units/kg up to adult total dose of 7.2 million units) 1

Common Pitfalls and Caveats

  • Do not confuse latent syphilis with neurosyphilis: Standard latent syphilis regimens may not be optimal for asymptomatic neurosyphilis, which requires IV penicillin 1
  • Doxycycline is not adequate for neurosyphilis - patients with CNS involvement require IV aqueous crystalline penicillin G regardless of penicillin allergy status 3
  • The efficacy of alternative regimens (doxycycline, tetracycline) in HIV-infected persons has not been studied and must be considered with caution 1
  • In rare instances, despite negative CSF examination and repeated therapy, serologic titers may still not decline - the need for additional therapy or repeated CSF examinations in these circumstances is unclear 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Syphilis When Penicillin G is Unavailable

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.